Specific to AD, FAAH inhibitors have demonstrated protective effects against amyloidosis, resulting in improved cognitive function, improved memory, lower oxidative stress, and lower neuroinflammation in an AD mouse model [60]. The gene discussed is FAAH; the disease is amyloidosis.